secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001493152-23-042857
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix signs research agreement with University of Michigan for RCT of UroShield
--------------------------------------------------------------------------------

- UroShield study targets nursing home residents; aims to reduce UTIs, catheter blockages, and pain.
- Pilot of 20 patients precedes full study of over 300 patients; expected to start H1 2024.
- Positive results could support application to FDA for permanent clearance; currently under Enforcement Discretion.
- Study led by Center for Research and Innovations in Special Populations (CRIISP) at University of Michigan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223042857/0001493152-23-042857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223042857/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-042857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer